Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06252675
Title Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors C. Babis Andreadis
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.